Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 262

1.

Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention.

Garcia D, Ageno W, Bussey H, Eikelboom J, Margaglione M, Marongiu F, Moia M, Palareti G, Pengo V, Poli D, Schulman S, Witt D, Wittkowksy A, Crowther M.

Am J Hematol. 2009 Sep;84(9):579-83. doi: 10.1002/ajh.21470. Review. No abstract available.

2.

Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment.

Ageno W, Garcia D, Aguilar MI, Douketis J, Finazzi G, Imberti D, Iorio A, Key NS, Lim W, Marietta M, Prisco D, Sarode R, Testa S, Tosetto A, Crowther M.

Am J Hematol. 2009 Sep;84(9):584-8. doi: 10.1002/ajh.21469. Review. No abstract available.

3.

Epidemiology and management of bleeding in patients using vitamin K antagonists.

Levi M.

J Thromb Haemost. 2009 Jul;7 Suppl 1:103-6. doi: 10.1111/j.1538-7836.2009.03389.x. Review.

4.

[Vitamin K antagonists: mechanism of anticoagulant action and laboratory control over therapy (a lecture)].

Lipatova NA, Titaeva EV, Dobrovol'skiĭ AB.

Klin Lab Diagn. 2006 May;(5):25-32. Russian. No abstract available.

PMID:
16827235
5.

[The interaction between anticoagulant therapy with vitamin K-antagonists and treatment with antibiotics: a practical recommendation].

Zelis M, Zweegman S, van der Meer FJ, Kramer MH, Smulders YM.

Ned Tijdschr Geneeskd. 2008 May 3;152(18):1042-6. Review. Dutch.

PMID:
18547025
6.

Reversal of vitamin K antagonist-associated coagulopathy: a survey of current practice.

Neal M, Crowther M, Douketis J, Verhovsek M, Stidley C, Garcia D.

Thromb Res. 2008;122(6):864-6. doi: 10.1016/j.thromres.2008.06.003. Epub 2008 Aug 3. No abstract available.

PMID:
18678398
7.

NovoSeven in warfarin-treated patients.

Berntorp E, Stigendal L, Lethagen S, Olofsson L, Hedner U.

Blood Coagul Fibrinolysis. 2000 Apr;11 Suppl 1:S113-5.

PMID:
10850575
8.

Optimal reversal of vitamin K antagonists.

Schulman S.

Thromb Res. 2007;119(1):15-6. Epub 2005 Nov 28. No abstract available.

PMID:
16310838
9.

Recommendations on bleeding and nonbleeding complications of vitamin K antagonists.

Ansell J.

Clin Adv Hematol Oncol. 2007 Jul;5(7):517-8, 554. No abstract available.

PMID:
17679924
10.

[Characteristics of the diagnosis and treatment of venous thrombosis. Benefit-risk relationship of anticoagulant treatment].

Samama MM.

Rev Med Suisse Romande. 1995 Apr;115(4):297-300. French. No abstract available.

PMID:
7740253
11.

[Risk and management of anti-vitamin K in the elderly].

Pautas E.

Rev Prat. 2009 Dec 20;59(10):1377-81. French.

PMID:
20058757
12.

[Monitoring antivitamin K treatment: a notebook for the patient].

Buxeraud J.

Rev Infirm. 2004 Apr;(100):38-41. French. No abstract available.

PMID:
15222184
13.

[Long-term oral anticoagulation. Self monitoring optimizes vitamin K antagonist therapy].

[No authors listed]

MMW Fortschr Med. 2014 Nov 20;156(20):79. German. No abstract available.

PMID:
25543379
14.

Reversing vitamin K antagonists: making the old new again.

Eichinger S.

Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):605-611. Review.

PMID:
27913535
15.

[Vitamin K antagonists and their successors. The Danish Society for Thrombosis and Hemostasis].

Nielsen JD; Dansk Selskab for Trombose og Haemostase.

Ugeskr Laeger. 2007 Mar 19;169(12):1134. Danish. No abstract available.

PMID:
17394845
16.

[Prothrombin complex concentrate or treatment of a iatrogenic disease].

Jaussaud R, Grivel T.

Rev Med Interne. 2010 Dec;31(9 Suppl):H17-21. doi: 10.1016/S0248-8663(10)70009-6. French. No abstract available.

PMID:
20965370
17.

Risk factors associated with a thrombotic or bleeding event in patients treated with vitamin K antagonists.

Béné J, Dubart AE, Senis C, Auffret M, Caron J, Gautier S.

J Mal Vasc. 2014 Jul;39(4):248-55. doi: 10.1016/j.jmv.2014.04.002. Epub 2014 Jun 2.

PMID:
24889788
18.

[Anticoagulation by oral treatment with vitamin K antagonists].

Kemkes-Matthes B.

Hamostaseologie. 2008 Dec;28(5):421-7. German.

PMID:
19132171
19.

Vitamin K to correct overanticoagulation.

Jindeel A.

Ann Intern Med. 2009 Sep 15;151(6):434; author reply 435. No abstract available.

PMID:
19755379
20.

Vitamin K to correct overanticoagulation.

Kumar PD.

Ann Intern Med. 2009 Sep 15;151(6):434-5; author reply 435. No abstract available.

PMID:
19755378

Supplemental Content

Support Center